Grants and Contributions:
Title:
Novel platform for high affinity recombinant chicken monoclonal antibodies
Agreement Number:
909745
Agreement Value:
$35,951.00
Agreement Date:
Jul 2, 2018 - Oct 31, 2019
Description:
The goal of this project is to develop a recombinant antibody platform using chickens.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Brackley, Prince Edward Island, CA C1E 1C4
Reference Number:
172-2018-2019-Q2-909745
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807019971
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 5,895 dollars.
Amendment Date
Oct 4, 2019
Recipient's Legal Name:
AffinityImmuno Inc.
Federal Riding Name:
Malpeque
Federal Riding Number:
11004
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: